JP2014532408A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014532408A5 JP2014532408A5 JP2014538896A JP2014538896A JP2014532408A5 JP 2014532408 A5 JP2014532408 A5 JP 2014532408A5 JP 2014538896 A JP2014538896 A JP 2014538896A JP 2014538896 A JP2014538896 A JP 2014538896A JP 2014532408 A5 JP2014532408 A5 JP 2014532408A5
- Authority
- JP
- Japan
- Prior art keywords
- usp2a
- sample
- disease
- seq
- level
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000000034 method Methods 0.000 claims 20
- 201000010099 disease Diseases 0.000 claims 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 11
- 108090000765 processed proteins & peptides Proteins 0.000 claims 9
- 108090000623 proteins and genes Proteins 0.000 claims 9
- 108020004707 nucleic acids Proteins 0.000 claims 8
- 102000039446 nucleic acids Human genes 0.000 claims 8
- 150000007523 nucleic acids Chemical class 0.000 claims 8
- 102000004169 proteins and genes Human genes 0.000 claims 8
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 5
- 244000144972 livestock Species 0.000 claims 3
- 238000003307 slaughter Methods 0.000 claims 3
- 238000002965 ELISA Methods 0.000 claims 2
- 206010028980 Neoplasm Diseases 0.000 claims 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 2
- 201000011510 cancer Diseases 0.000 claims 2
- 238000012544 monitoring process Methods 0.000 claims 2
- 238000003752 polymerase chain reaction Methods 0.000 claims 2
- 238000003127 radioimmunoassay Methods 0.000 claims 2
- 238000012340 reverse transcriptase PCR Methods 0.000 claims 2
- 238000000636 Northern blotting Methods 0.000 claims 1
- 206010060862 Prostate cancer Diseases 0.000 claims 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims 1
- 108700008625 Reporter Genes Proteins 0.000 claims 1
- 238000012300 Sequence Analysis Methods 0.000 claims 1
- 238000002105 Southern blotting Methods 0.000 claims 1
- 150000001413 amino acids Chemical class 0.000 claims 1
- 210000004369 blood Anatomy 0.000 claims 1
- 239000008280 blood Substances 0.000 claims 1
- 210000004027 cell Anatomy 0.000 claims 1
- 238000001514 detection method Methods 0.000 claims 1
- 238000003119 immunoblot Methods 0.000 claims 1
- 238000010166 immunofluorescence Methods 0.000 claims 1
- 238000003364 immunohistochemistry Methods 0.000 claims 1
- 238000001114 immunoprecipitation Methods 0.000 claims 1
- 238000007901 in situ hybridization Methods 0.000 claims 1
- 238000010208 microarray analysis Methods 0.000 claims 1
- 210000002966 serum Anatomy 0.000 claims 1
- 239000000758 substrate Substances 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
- 210000001519 tissue Anatomy 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161551567P | 2011-10-26 | 2011-10-26 | |
| US61/551,567 | 2011-10-26 | ||
| PCT/US2012/061543 WO2013063010A1 (en) | 2011-10-26 | 2012-10-24 | Usp2a peptides and antibodies |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014532408A JP2014532408A (ja) | 2014-12-08 |
| JP2014532408A5 true JP2014532408A5 (https=) | 2015-12-10 |
Family
ID=48168402
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014538896A Withdrawn JP2014532408A (ja) | 2011-10-26 | 2012-10-24 | USP2aペプチドおよび抗体 |
Country Status (6)
| Country | Link |
|---|---|
| US (5) | US9056919B2 (https=) |
| EP (1) | EP2771689A4 (https=) |
| JP (1) | JP2014532408A (https=) |
| AU (1) | AU2012328989A1 (https=) |
| CA (1) | CA2852629A1 (https=) |
| WO (1) | WO2013063010A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015026893A1 (en) * | 2013-08-20 | 2015-02-26 | Nuclea Biotechnologies, Inc. | Predictive biomarkers for metabolic syndrome |
| CN108396020B (zh) * | 2018-02-02 | 2020-10-13 | 武汉大学 | USP2a的D357A或S207/225A突变体在抑制肿瘤转移中的应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6436703B1 (en) | 2000-03-31 | 2002-08-20 | Hyseq, Inc. | Nucleic acids and polypeptides |
| CA2421922A1 (en) * | 2000-09-08 | 2002-03-14 | Incyte Genomics, Inc. | Proteases |
| US6927056B2 (en) * | 2001-09-06 | 2005-08-09 | Incyte Corporation | Proteases |
| WO2004023973A2 (en) * | 2002-09-12 | 2004-03-25 | Incyte Corporation | Molecules for diagnostics and therapeutics |
| US7641855B2 (en) | 2006-08-25 | 2010-01-05 | Siemens Healthcare Diagnostics Inc. | System for automatically storing and reprocessing patient samples in an automatic clinical analyzer |
| JP2010510528A (ja) * | 2006-11-22 | 2010-04-02 | ライフ テクノロジーズ コーポレーション | 自己免疫疾患のバイオマーカー |
| AU2012253708A1 (en) * | 2011-05-10 | 2013-11-07 | Nuclea Biotechnologies, Inc. | Predictive biomarkers for prostate cancer |
-
2012
- 2012-10-24 US US13/659,173 patent/US9056919B2/en not_active Expired - Fee Related
- 2012-10-24 JP JP2014538896A patent/JP2014532408A/ja not_active Withdrawn
- 2012-10-24 AU AU2012328989A patent/AU2012328989A1/en not_active Abandoned
- 2012-10-24 CA CA2852629A patent/CA2852629A1/en not_active Abandoned
- 2012-10-24 WO PCT/US2012/061543 patent/WO2013063010A1/en not_active Ceased
- 2012-10-24 EP EP12844526.9A patent/EP2771689A4/en not_active Withdrawn
-
2013
- 2013-05-16 US US13/895,393 patent/US20130237691A1/en not_active Abandoned
- 2013-05-16 US US13/895,405 patent/US20130237449A1/en not_active Abandoned
- 2013-05-16 US US13/895,399 patent/US20130303744A1/en not_active Abandoned
-
2015
- 2015-04-17 US US14/689,797 patent/US20150218290A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2014123511A (ru) | Способы лечения, диагностики и мониторинга болезни альцгеймера | |
| JP2013500001A5 (https=) | ||
| CN103834729A (zh) | 肺癌的多基因预后试验 | |
| KR20070051286A (ko) | 방광암 검출용 소변 표지 | |
| KR20120047334A (ko) | 자궁내막암 마커 | |
| RU2015138992A (ru) | Способы прогнозирования риска интерстициальной пневмонии | |
| US10895572B2 (en) | Autophagy-related nourin gene-based RNA network as early biomarkers for cardiac patients | |
| KR20180082328A (ko) | 전립선 암 예측 방법 | |
| JP2008509673A5 (https=) | ||
| JPWO2003014395A1 (ja) | 気管支喘息の検査方法 | |
| BR112019011031A2 (pt) | Método para estratificação de risco, produto de programa de computador, kit de diagnóstico e uso de um perfil de expressão gênica para estratificação de risco | |
| JP2017176186A (ja) | 線維症感受性il22ra2遺伝子およびその使用 | |
| JP2014532408A5 (https=) | ||
| CN113774140A (zh) | 一种预测结直肠癌对奥沙利铂治疗敏感性的产品 | |
| CN111315897B (zh) | 用于黑素瘤检测的方法 | |
| CN116445606A (zh) | 血清分子标志物comp在辅助诊断抑郁症中的应用 | |
| US20240410005A1 (en) | Methods for predicting drug responsiveness in heart failure subjects | |
| CN114959005B (zh) | 基于分子标志物的肥厚型心肌病诊断产品及其应用 | |
| WO2008031165A1 (en) | Methods and compositions for the diagnosis and treatment of tumours | |
| CN115058512A (zh) | 铁死亡相关基因在鉴定缺血性脑卒中的应用 | |
| CN113846165A (zh) | 生物标志物在预测结直肠癌对奥沙利铂治疗敏感性中的应用 | |
| CN113817829A (zh) | 生物标志物在制备预测结直肠癌对奥沙利铂治疗敏感性的产品中的用途 | |
| WO2007053659A2 (en) | Method of screening for hepatocellular carcinoma | |
| KR102781057B1 (ko) | Mpz 유전자의 돌연변이를 포함하는, 신규한 샤르코-마리-투스병 진단용 바이오마커 및 이의 용도 | |
| WO2008129265A1 (en) | Diagnostics and therapeutics for diabetic nephropathy involving ccl18 |